BlackRock Inc. - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 33 filers reported holding TREVI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,683,214
-12.3%
2,148,263
-3.9%
0.00%
Q2 2023$5,341,318
+3410.5%
2,234,861
+2617.3%
0.00%
Q1 2023$152,154
-2.4%
82,245
+1.8%
0.00%
Q4 2022$155,887
+73.2%
80,771
+37.3%
0.00%
Q3 2022$90,000
-44.1%
58,824
+2.3%
0.00%
Q2 2022$161,000
+120.5%
57,494
+71.9%
0.00%
Q1 2022$73,000
+108.6%
33,439
-25.6%
0.00%
Q4 2021$35,000
-42.6%
44,948
+2.4%
0.00%
Q3 2021$61,000
-38.4%
43,899
-0.6%
0.00%
Q2 2021$99,000
+13.8%
44,180
+36.4%
0.00%
Q1 2021$87,000
+55.4%
32,394
+40.6%
0.00%
Q4 2020$56,000
-37.1%
23,037
+4.2%
0.00%
Q3 2020$89,000
-42.6%
22,118
-6.7%
0.00%
Q2 2020$155,000
+416.7%
23,713
+161.4%
0.00%
Q1 2020$30,000
+7.1%
9,072
+23.4%
0.00%
Q4 2019$28,000
+460.0%
7,349
+531.4%
0.00%
Q3 2019$5,000
-80.8%
1,164
-66.6%
0.00%
Q2 2019$26,0003,4840.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 11,370,376$24,787,4201.91%
Fairmount Funds Management LLC 5,163,287$11,255,9661.35%
Opaleye Management Inc. 1,705,900$3,718,8621.21%
Frazier Life Sciences Management, L.P. 6,881,090$15,000,7761.00%
VR Adviser, LLC 3,422,397$7,460,8250.78%
SILVERARC CAPITAL MANAGEMENT, LLC 927,415$2,021,7650.61%
Rubric Capital Management LP 5,684,420$12,392,0360.46%
Tejara Capital Ltd 180,227$392,8950.22%
PFS Partners, LLC 100,000$218,0000.19%
WealthTrust Axiom LLC 93,500$203,8300.07%
View complete list of TREVI THERAPEUTICS INC shareholders